{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:24:06Z","timestamp":1794493446649,"version":"4.9.1"},"reference-count":146,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100003064","name":"Kidney Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013920","name":"VHL Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eururo.2025.06.005","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T20:14:45Z","timestamp":1753992885000},"page":"341-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors"],"prefix":"10.1016","volume":"88","author":[{"given":"Alessandro","family":"Larcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddie","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bukavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jonasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmedin","family":"Jemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Marston Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Marandino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carmen","family":"Mir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mollica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Shuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant D.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuna","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxine","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kutikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.06.005_b0005","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.06.005_b0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014part A: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.eururo.2022.11.001","article-title":"European Association of Urology Guidelines Panel on renal cell carcinoma update on the new World Health Organization classification of kidney tumours 2022: the urologist\u2019s point of view","volume":"83","author":"Hora","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology guidelines on renal cell carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0025","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2014.04.029","article-title":"Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity","volume":"67","author":"Shuch","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0040","unstructured":"Ferlay J, Laversanne M, Ervik M, et al. Global Cancer Observatory: cancer today (version 1.1). Lyon, France: International Agency for Research on Cancer. https:\/\/gco.iarc.who.int\/today."},{"key":"10.1016\/j.eururo.2025.06.005_b0045","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho","year":"2024","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0050","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.06.005_b0055","doi-asserted-by":"crossref","unstructured":"Doll R, Payne PM, Waterhouse JAH. Cancer incidence in five continents 1966:19\u201324. https:\/\/doi.org\/10.1007\/978-3-642-85849-9_3.","DOI":"10.1007\/978-3-642-85849-9_3"},{"key":"10.1016\/j.eururo.2025.06.005_b0060","unstructured":"Ferlay J, Laversanne M, Ervik M, et al. Global Cancer Observatory: cancer tomorrow (version 1.1). Lyon, France: International Agency for Research on Cancer. https:\/\/gco.iarc.who.int\/tomorrow."},{"key":"10.1016\/j.eururo.2025.06.005_b0065","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41571-021-00514-z","article-title":"Planning for tomorrow: global cancer incidence and the role of prevention 2020\u20132070","volume":"18","author":"Soerjomataram","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0075","unstructured":"Orphanet. An online rare disease and orphan drug data base \u00a9 INSERM 1999; 2025. http:\/\/www.orpha.net."},{"key":"10.1016\/j.eururo.2025.06.005_b0080","unstructured":"NHS England. Cancer survival in England, cancers diagnosed 2016 to 2020, followed up to 2021. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cancer-survival-in-england\/index-for-sub-integrated-care-boards-2005-to-2020."},{"key":"10.1016\/j.eururo.2025.06.005_b0085","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER Research Plus Limited-Field Data, 22 Registries (excl IL and MA), Nov 2023 Sub (2000-2021) - Linked To County Attributes - Total U.S., 1969-2022 Counties. DCCPS, Surveillance Research Program, released April 2024. http:\/\/www.seer.cancer.gov."},{"key":"10.1016\/j.eururo.2025.06.005_b0090","unstructured":"Australian Institute of Health and Welfare (AIHW). Cancer data in Australia; 2024. https:\/\/www.aihw.gov.au\/reports\/cancer\/cancer-data-in-australia."},{"key":"10.1016\/j.eururo.2025.06.005_b0095","doi-asserted-by":"crossref","unstructured":"Delam H, Keshtkaran Z, Eidi A, et al. Survival rate of kidney cancer in the Asian countries: a systematic review and meta-analysis study; 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2706310\/v1.","DOI":"10.21203\/rs.3.rs-2706310\/v1"},{"key":"10.1016\/j.eururo.2025.06.005_b0100","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.3332\/ecancer.2023.1524","article-title":"Clinical pathological characteristics and treatment outcomes of renal cell carcinoma (RCC): a retrospective study from Sudan","volume":"17","author":"Bafadni","year":"2023","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.eururo.2025.06.005_b0105","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.2147\/CMAR.S361765","article-title":"Epidemiological and histopathological characteristics of renal cell carcinoma in Somalia","volume":"14","author":"Mohamed","year":"2022","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.eururo.2025.06.005_b0110","doi-asserted-by":"crossref","unstructured":"Zequi S de C, Mour\u00e3o TC, Oliveira MM de, et al. Predictors of survival outcomes in non-metastatic renal cell carcinoma in Latin America and Spain: a multicentric analysis. Kidney Cancer 2019;3:253\u201361.","DOI":"10.3233\/KCA-190068"},{"key":"10.1016\/j.eururo.2025.06.005_b0115","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN \u2013 a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0120","unstructured":"National Cancer Institute. SEER*Explorer: An interactive website for SEER cancer statistics [Internet]. Surveillance Research Program, National Cancer Institute; 2024 Apr 17. https:\/\/seer.cancer.gov\/statistics-network\/explorer\/."},{"key":"10.1016\/j.eururo.2025.06.005_b0125","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/jamaoncol.2018.1986","article-title":"Prevalence of germline mutations in cancer susceptibility genes in patients with advanced renal cell carcinoma","volume":"4","author":"Carlo","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0130","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1200\/JCO.19.02263","article-title":"Growth rates of genetically defined renal tumors: implications for active surveillance and intervention","volume":"38","author":"Ball","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JU.0000000000001911","article-title":"Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I","volume":"206","author":"Campbell","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5489\/cuaj.1496","article-title":"Canadian guideline on genetic screening for hereditary renal cell cancers","volume":"7","author":"Reaume","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.eururo.2025.06.005_b0145","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0150","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.6004\/jnccn.2024.0008","article-title":"NCCN Guidelines\u00ae insights: kidney cancer, version 2.2024: featured updates to the NCCN guidelines","volume":"22","author":"Motzer","year":"2024","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.eururo.2025.06.005_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature19795","article-title":"On-target efficacy of a HIF-2\u03b1 antagonist in preclinical kidney cancer models","volume":"539","author":"Cho","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2025.06.005_b0165","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cell.2018.02.020","article-title":"Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal","volume":"173","author":"Mitchell","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2025.06.005_b0170","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1093\/hmg\/ddac066","article-title":"Elongin C (ELOC\/TCEB1)-associated von Hippel\u2013Lindau disease","volume":"31","author":"Andreou","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor\u2010prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.eururo.2025.06.005_b0180","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ejhg.2016.173","article-title":"Prevalence, birth incidence, and penetrance of von Hippel\u2013Lindau disease (vHL) in Denmark","volume":"25","author":"Binderup","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0185","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1002\/cncr.30893","article-title":"Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test","volume":"123","author":"Nguyen","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0190","article-title":"Trans-ethnic variation in germline variants of patients with renal cell carcinoma","volume":"34","author":"Alaiwi","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.eururo.2025.06.005_b0195","first-page":"1962","article-title":"Different risk genes contribute to clear cell and non-clear cell renal cell carcinoma in 1532 Japanese patients and 5996 controls","volume":"31","author":"Sekine","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0200","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cncr.35074","article-title":"Genomic ancestry in kidney cancer: correlations with clinical and molecular features","volume":"130","author":"Kotecha","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0205","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1093\/hmg\/ddac089","article-title":"Frequency of pathogenic germline variants in cancer susceptibility genes in 1336 renal cell carcinoma cases","volume":"31","author":"Yngvadottir","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0210","article-title":"Germline susceptibility to renal cell carcinoma and implications for genetic screening","volume":"8","author":"Glennon","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0215","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3390\/cancers16172985","article-title":"Prevalence of germline pathogenic variants in renal cancer predisposition genes in a population-based study of renal cell carcinoma","volume":"16","author":"Bruinsma","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.eururo.2025.06.005_b0220","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.06.005_b0225","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41585-024-00874-y","article-title":"Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease","volume":"21","author":"Larcher","year":"2024","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0230","article-title":"von Hippel-Lindau disease: updated guideline for diagnosis and surveillance","volume":"65","author":"Binderup","year":"2022","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0235","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/cncr.34896","article-title":"Guidelines for surveillance of patients with von Hippel-Lindau disease: Consensus statement of the International VHL Surveillance Guidelines Consortium and VHL Alliance","volume":"129","author":"Daniels","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0240","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1007\/s00345-020-03574-5","article-title":"Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortium","volume":"39","author":"Capitanio","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0245","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/MOU.0000000000000950","article-title":"Von Hippel-Lindau disease-associated renal cell carcinoma: a call to action","volume":"32","author":"Larcher","year":"2022","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0250","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for renal cell carcinoma in von Hippel-Lindau disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0255","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S1470-2045(24)00389-9","article-title":"Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study","volume":"25","author":"Iliopoulos","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0260","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S1470-2045(18)30487-X","article-title":"Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial","volume":"19","author":"Jonasch","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0265","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.euo.2024.01.003","article-title":"Removing barriers to the use of systemic agents for patients with von Hippel-Lindau disease","volume":"7","author":"Larcher","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0270","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ajmg.c.31651","article-title":"Genetics, genomics, and genotype\u2013phenotype correlations of TSC: Insights for clinical practice","volume":"178","author":"Peron","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41379-021-00971-y","article-title":"Renal cell carcinoma associated with tuberous sclerosis complex (TSC)\/mammalian target of rapamycin (MTOR) genetic alterations","volume":"35","author":"Argani","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.eururo.2025.06.005_b0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13023-018-0870-y","article-title":"Incidence of tuberous sclerosis and age at first diagnosis: new data and emerging trends from a national, prospective surveillance study","volume":"13","author":"Ebrahimi-Fakhari","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.eururo.2025.06.005_b0285","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/PAS.0000000000000248","article-title":"Tuberous sclerosis\u2013associated renal cell carcinoma","volume":"38","author":"Guo","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2025.06.005_b0290","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1474-4422(22)00213-7","article-title":"Advances in the genetics and neuropathology of tuberous sclerosis complex: edging closer to targeted therapy","volume":"21","author":"Curatolo","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2025.06.005_b0295","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","article-title":"Metabolic alterations in hereditary and sporadic renal cell carcinoma","volume":"20","author":"Coffey","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.eururo.2025.06.005_b0300","first-page":"12","article-title":"Hereditary renal cancer syndromes","volume":"12","author":"Yanus","year":"2024","journal-title":"Med Sci"},{"key":"10.1016\/j.eururo.2025.06.005_b0305","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-5347(17)35015-2","article-title":"Hereditary papillary renal cell carcinoma","volume":"151","author":"Zbar","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0310","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/01.ju.0000139583.63354.e0","article-title":"Early onset hereditary papillary renal carcinoma","volume":"172","author":"Schmidt","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1053\/j.semdp.2023.12.002","article-title":"Hereditary papillary renal cell carcinoma","volume":"41","author":"Jacoba","year":"2024","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.eururo.2025.06.005_b0320","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","article-title":"FLCN: the causative gene for Birt-Hogg-Dub\u00e9 syndrome","volume":"640","author":"Schmidt","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.eururo.2025.06.005_b0325","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/jmp5040032","article-title":"Molecular pathogenesis of renal neoplasms in patients with Birt\u2013Hogg\u2013Dub\u00e9 syndrome","volume":"5","author":"Nezami","year":"2024","journal-title":"J Mol Pathol"},{"key":"10.1016\/j.eururo.2025.06.005_b0330","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.urology.2023.04.035","article-title":"PRDM10 RCC: A Birt-Hogg-Dub\u00e9-like syndrome associated with lipoma and highly penetrant, aggressive renal tumors morphologically resembling type 2 papillary renal cell carcinoma","volume":"179","author":"Schmidt","year":"2023","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2025.06.005_b0335","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.gim.2022.05.006","article-title":"Frequency of truncating FLCN variants and Birt-Hogg-Dub\u00e9\u2013associated phenotypes in a health care system population","volume":"24","author":"Savatt","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0340","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cancergen.2025.01.007","article-title":"Clinical and genetic characteristics in two cases of Birt-Hogg-Dub\u00e9 syndrome associated with papillary renal cell carcinoma and rare Folliculin (FLCN) variants","volume":"292\u2013293","author":"Evans","year":"2025","journal-title":"Cancer Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0345","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2024.2449271","article-title":"Trends in pulmonary function in patients with Birt-Hogg-Dub\u00e9 syndrome: a retrospective cohort study","volume":"12","author":"Holmager","year":"2025","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.eururo.2025.06.005_b0350","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s13023-024-03360-1","article-title":"Clinical and genetic characteristics of 100 consecutive patients with Birt-Hogg-Dub\u00e9 syndrome in Eastern Chinese region","volume":"19","author":"Hu","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.eururo.2025.06.005_b0355","first-page":"1","article-title":"Kidney cancer: links between hereditary syndromes and sporadic tumorigenesis","volume":"41","author":"Alchoueiry","year":"2024","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.eururo.2025.06.005_b0360","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1002\/cncr.33679","article-title":"Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement","volume":"127","author":"Bratslavsky","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0365","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.euros.2024.02.006","article-title":"Integrative analysis of germline rare variants in clear and non\u2013clear cell renal cell carcinoma","volume":"62","author":"Han","year":"2024","journal-title":"Eur Urol Open Sci"},{"key":"10.1016\/j.eururo.2025.06.005_b0370","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41588-024-01725-7","article-title":"Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions","volume":"56","author":"Purdue","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.eururo.2025.06.005_b0375","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.eururo.2014.10.002","article-title":"International variations and trends in renal cell carcinoma incidence and mortality","volume":"67","author":"Znaor","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0380","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MOU.0000000000000603","article-title":"Gender-specific risk factors for renal cell carcinoma: a systematic review","volume":"29","author":"Lughezzani","year":"2019","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/JU.0000000000002506","article-title":"Familial risk of renal cell cancer and interaction with obesity and hyperglycemia: a population-based study","volume":"208","author":"Lee","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0390","first-page":"405","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019","volume":"74","author":"Islami","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.06.005_b0395","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41585-023-00781-8","article-title":"Effect of smoking, hypertension and lifestyle factors on kidney cancer\u2014perspectives for prevention and screening programmes","volume":"20","author":"Campi","year":"2023","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0400","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.06.005_b0405","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0410","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2022.04.032","article-title":"Obesity in relation to renal cell carcinoma incidence and survival in three prospective studies","volume":"82","author":"Graff","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0415","article-title":"The association between BMI and kidney cancer risk","volume":"97","author":"Liu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.eururo.2025.06.005_b0420","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/JU.0000000000001377","article-title":"A systematic review and meta-analysis of the significance of body mass index on kidney cancer outcomes","volume":"205","author":"Kim","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0425","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(19)30797-1","article-title":"Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study","volume":"21","author":"Sanchez","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0430","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1016\/j.clgc.2023.03.006","article-title":"Clinico-pathological features influencing the prognostic role of body mass index in patients with advanced renal cell carcinoma treated by immuno-oncology combinations (ARON-1)","volume":"21","author":"Santoni","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0435","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1200\/JCO.2016.66.7311","article-title":"Body mass index and metastatic renal cell carcinoma: clinical and biological correlations","volume":"34","author":"Albiges","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0440","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccell.2015.12.004","article-title":"An integrated metabolic atlas of clear cell renal cell carcinoma","volume":"29","author":"Hakimi","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.eururo.2025.06.005_b0445","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.urolonc.2018.12.008","article-title":"Systematic review of modifiable risk factors for kidney cancer","volume":"37","author":"Al-Bayati","year":"2019","journal-title":"Urol Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0450","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc14-1996","article-title":"Cancer risk among people with type 1 and type 2 diabetes: disentangling true associations, detection bias, and reverse causation","volume":"38","author":"Harding","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eururo.2025.06.005_b0455","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 diabetes and cancer: an umbrella review of observational and Mendelian randomization studies","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.eururo.2025.06.005_b0460","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s12079-019-00512-y","article-title":"Insulin and insulin\u2010like growth factors act as renal cell cancer intratumoral regulators","volume":"13","author":"Solarek","year":"2019","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.eururo.2025.06.005_b0465","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2174\/0118715303256408230925060414","article-title":"Meta-analysis of the relationship between type 2 diabetes mellitus and renal cancer risk","volume":"24","author":"Wang","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.eururo.2025.06.005_b0470","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12916-024-03430-y","article-title":"Diabetes and further risk of cancer: a nationwide population-based study","volume":"22","author":"Chang","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0475","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1186\/s12967-023-04555-z","article-title":"Association of diabetes risk reduction diet with renal cancer risk in 101,755 participants: a prospective study","volume":"21","author":"Xiang","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0480","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.euo.2024.04.006","article-title":"Association between GLP1R agonists and prostate, kidney, and bladder cancers","volume":"7","author":"Bukavina","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0485","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.21305","article-title":"Glucagon-like peptide 1 receptor agonists and 13 obesity-associated cancers in patients with type 2 diabetes","volume":"7","author":"Wang","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.06.005_b0490","first-page":"298","article-title":"The VHL tumor suppressor gene: insights into oxygen sensing and cancer","volume":"128","author":"Kaelin","year":"2017","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.eururo.2025.06.005_b0495","first-page":"1317","article-title":"The relationship between blood pressure and risk of renal cell carcinoma","volume":"51","author":"Alcala","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eururo.2025.06.005_b0500","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.18632\/aging.102699","article-title":"Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis","volume":"12","author":"Xie","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.eururo.2025.06.005_b0505","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ijc.34032","article-title":"Higher genetically predicted low\u2010density lipoprotein levels increase the renal cancer risk independent of triglycerides and high\u2010density lipoprotein levels: a Mendelian randomization study","volume":"151","author":"Ma","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0510","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12944-024-02138-5","article-title":"Association between metabolic syndrome and kidney cancer risk: a prospective cohort study","volume":"23","author":"Wang","year":"2024","journal-title":"Lipids Heal Dis"},{"key":"10.1016\/j.eururo.2025.06.005_b0515","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2025.06.005_b0520","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","article-title":"Renal cell carcinoma","volume":"404","author":"Young","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.06.005_b0525","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.eururo.2018.07.029","article-title":"Below safety limits, every unit of glomerular filtration rate counts: assessing the relationship between renal function and cancer-specific mortality in renal cell carcinoma","volume":"74","author":"Antonelli","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0530","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.18632\/oncotarget.24724","article-title":"Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: a retrospective study of 422,010 patients followed for up to 30 years","volume":"9","author":"Jacob","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.eururo.2025.06.005_b0535","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2023-0347","article-title":"\u0394Np63\u03b1 promotes cigarette smoke-induced renal cancer stem cell activity via the Sonic Hedgehog pathway","volume":"47","author":"Zhao","year":"2024","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.eururo.2025.06.005_b0540","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.critrevonc.2019.07.019","article-title":"Dose-response relationships between cigarette smoking and kidney cancer: a systematic review and meta-analysis","volume":"142","author":"Liu","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.eururo.2025.06.005_b0545","doi-asserted-by":"crossref","first-page":"14756","DOI":"10.1002\/cam4.6104","article-title":"The prognostic role of cigarette smoking in kidney cancer survival","volume":"12","author":"Baral","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0550","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1200\/jco.2015.33.7_suppl.505","article-title":"Predicting pulmonary metastases among patients with indeterminate pulmonary nodules with renal cell carcinoma","volume":"33","author":"Adibi","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0555","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00345-024-05041-x","article-title":"Pulmonary lesion after surgery for renal cancer: progression or new primary?","volume":"42","author":"Cignoli","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0560","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00345-023-04546-1","article-title":"The genitourinary impacts of electronic cigarette use: a systematic review of the literature","volume":"41","author":"Bandara","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0565","first-page":"167","article-title":"Comparison of conventional cigarette and electronic cigarettes on P53, PTEN, and VEGF genes expression in rat kidney","volume":"5","author":"Jahanshahi","year":"2023","journal-title":"Transl Res Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0570","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/ijc.30587","article-title":"Outdoor air pollution and risk for kidney parenchyma cancer in 14 European cohorts","volume":"140","author":"Raaschou-Nielsen","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0575","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/oem.2010.056341","article-title":"Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case\u2013control study from Central and Eastern Europe","volume":"68","author":"Boffetta","year":"2011","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0580","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2215\/CJN.04670418","article-title":"Perfluorinated chemicals as emerging environmental threats to kidney health: a scoping review","volume":"13","author":"Stanifer","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.eururo.2025.06.005_b0585","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00345-022-04100-5","article-title":"Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review","volume":"41","author":"Dickman","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0590","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3390\/ijerph19020618","article-title":"Kidney cancer risk associated with historic groundwater trichloroethylene contamination","volume":"19","author":"Andrew","year":"2022","journal-title":"Int J Environ Res Public Heal"},{"key":"10.1016\/j.eururo.2025.06.005_b0595","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00441-022-03581-5","article-title":"Screening for polystyrene nanoparticle toxicity on kidneys of adult male albino rats using histopathological, biochemical, and molecular examination results","volume":"388","author":"Ahmed","year":"2022","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.eururo.2025.06.005_b0600","doi-asserted-by":"crossref","first-page":"17976","DOI":"10.1038\/srep17976","article-title":"Association between cadmium exposure and renal cancer risk: a meta-analysis of observational studies","volume":"5","author":"Song","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.eururo.2025.06.005_b0605","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.2018.79.1905","article-title":"Epidemiology and risk factors for kidney cancer","volume":"36","author":"Scelo","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0610","first-page":"816","article-title":"Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults. JAMA","volume":"176","author":"Moore","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0615","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.annepidem.2011.04.012","article-title":"A prospective analysis of prolonged sitting time and risk of renal cell carcinoma among 300,000 older adults","volume":"21","author":"George","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.eururo.2025.06.005_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1344891","article-title":"Ketogenic diet enhances the anti-cancer effects of PD-L1 blockade in renal cell carcinoma","volume":"15","author":"Richard","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.eururo.2025.06.005_b0625","doi-asserted-by":"crossref","first-page":"984","DOI":"10.4143\/crt.2017.248","article-title":"Effects of aspirin, nonsteroidal anti-inflammatory drugs, statin, and COX2 inhibitor on the developments of urological malignancies: a population-based study with 10-year follow-up data in Korea","volume":"50","author":"Kang","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.eururo.2025.06.005_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2021.102036","article-title":"Analgesic use and the risk of renal cell carcinoma\u2014findings from the Consortium for the Investigation of Renal Malignancies (CONFIRM) study","volume":"75","author":"Bruinsma","year":"2021","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.eururo.2025.06.005_b0635","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose\u2013response meta-analysis","volume":"112","author":"Bagnardi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2025.06.005_b0640","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20382","article-title":"Association of the frequency and quantity of alcohol consumption with gastrointestinal cancer","volume":"4","author":"Yoo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.06.005_b0645","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0140-6736(25)00187-4","article-title":"Should alcohol carry cancer warning labels?","volume":"405","author":"Devi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.06.005_b0650","first-page":"101","article-title":"Coffee consumption and risk of renal cancer: a meta-analysis of cohort evidence","volume":"33","author":"Rhee","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.eururo.2025.06.005_b0655","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/MLR.0000000000000657","article-title":"Understanding treatment disconnect and mortality trends in renal cell carcinoma using tumor registry data","volume":"55","author":"Smaldone","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.eururo.2025.06.005_b0660","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3390\/cancers15102782","article-title":"Survival in kidney and bladder cancers in four Nordic countries through a half century","volume":"15","author":"Tichanek","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.eururo.2025.06.005_b0665","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.06.005_b0670","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.eururo.2025.06.005_b0675","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2025.06.005_b0680","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067875","article-title":"Trends in age of tobacco use initiation over time in Bangladesh, India and Pakistan: analysis of cross-sectional nationally representative surveys","volume":"13","author":"Singh","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2025.06.005_b0685","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.27465","article-title":"Trends in tobacco use among adolescents by grade, sex, and race, 1991\u20132019","volume":"3","author":"Meza","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.06.005_b0690","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1200\/JCO.2018.79.2523","article-title":"Genetic predisposition to renal cell carcinoma: implications for counseling, testing, screening, and management","volume":"36","author":"Shuch","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0695","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2025.06.005_b0700","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1158\/1078-0432.CCR-07-4921","article-title":"Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors","volume":"14","author":"Nickerson","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eururo.2025.06.005_b0705","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2019.02.048","article-title":"The missing diversity in human genetic studies","volume":"177","author":"Sirugo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.eururo.2025.06.005_b0710","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/s41585-020-0363-3","article-title":"Current evidence on screening for renal cancer","volume":"17","author":"Usher-Smith","year":"2020","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0715","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s00345-022-03993-6","article-title":"Screening programs for renal cell carcinoma: a systematic review by the EAU Young Academic Urologists Renal Cancer Working Group","volume":"41","author":"Diana","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0720","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063018","article-title":"The Yorkshire Kidney Screening Trial (YKST): protocol for a feasibility study of adding non-contrast abdominal CT scanning to screen for kidney cancer and other abdominal pathology within a trial of community-based CT screening for lung cancer","volume":"12","author":"Usher-Smith","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2025.06.005_b0725","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eururo.2024.08.029","article-title":"Abdominal noncontrast computed tomography scanning to screen for kidney cancer and other abdominal pathology within community-based computed tomography screening for lung cancer: results of the Yorkshire Kidney Screening Trial","volume":"87","author":"Stewart","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.06.005_b0730","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/bju.16316","article-title":"Psychosocial outcomes in the Yorkshire Kidney Screening Trial: moving the needle toward targeted screening for renal cell carcinoma","volume":"133","author":"Campi","year":"2024","journal-title":"BJU Int"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825003458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283825003458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:12:14Z","timestamp":1758697934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283825003458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":146,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0302283825003458"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.06.005","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology of Renal Cancer: Incidence, Mortality, Survival, Genetic Predisposition, and Risk Factors","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}